2022 NCSCG Liver Symposium
Come, Re-Connect with Colleagues and Learn from Leading Experts in Hepatology at the 2022 Annual Liver Symposium, Being Held In-person and Online!
Time & Location
Jan 29, 2022, 7:00 AM – 5:00 PM PST
San Francisco, 888 Howard St, San Francisco, CA 94103, USA
About the Event
The Northern California Society for Clinical Gastroenterology (NCSCG) is pleased to announce the hybrid 2022 Liver Symposium being held January 29, 2022, both online and in-person at the InterContinental San Francisco, CA.
The symposium will provide a unique opportunity to receive a comprehensive update in chronic liver disease from nationally renowned faculty. The educational lectures at this symposium will focus on important advances presented at the annual American Association for the Study of Liver Disease (AASLD) Meeting and/or in recent publications. You will also have ample opportunity to interact with colleagues, our expert faculty members, and industry representatives.
For questions or inquiries, please contact the NCSCG via email at email@example.com.
This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease.
Statement of Need
The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease.
Upon completion of this symposium, participants should be better able to:
- Describe chronic liver disease (CLD) management recommendations/guidelines for new treatments
- Optimize treatment results for patients with CLD, through utilizing new therapies
- Identify new advances presented at 2021 AASLD and assess their potential impact on clinical practice
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of the Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Southern California Society of Gastroenterology (SCSG). RMCHCS is accredited by NMMS to provide continuing medical education for physicians.
RMCHCS designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 6.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
The Liver Symposium Co-Chair Committee
Edward W. Holt, MD; NCSCG President
Allison Kwong, MD; Board Member
Marina Roytman, MD, FACP; Board Member
Sandip Suprai, DNP, RN, FNP-BC; Board Member
This activity is supported by an educational grant from Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A, Inc.
In-Person MD / DO / PhD
In-Person Allied HCP
In-Person Industry Rep
Virtual MD / DO / PhD
Virtual Allied HCP
Virtual Industry Rep